Clinical Trial Update: Scotoma Reduction in AMD Patients Treated With Ranibizumab [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial update reporting scotoma reduction in patients with age-related macular degeneration treated with ranibizumab.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration

Drugs mentioned

• Lucentis (ranibizumab)

Snippet

Sponsor: Retina Research Foundation | Conditions: Macular Degeneration | Phase 1, Phase 2 | Status: COMPLETED